Capitol attack committee: ‘no choice’ but to advance contempt proceedings for Meadows – live | US news










18:01

Today so far










17:42

Updated










17:24

Biden warns of ‘economic consequences like none he’s ever seen’ if Putin invades Ukraine

Updated










16:54

Updated










16:37

Three Pfizer jabs likely to protect against Omicron, tests suggest

Three shots of the Pfizer/BioNTech vaccine are likely to provide effective protection against the Omicron variant, laboratory tests suggest.

The vaccine makers said they were keeping the option of an updated Omicron-based vaccine on the table, however, and could produce it by March 2022 if needed.

In the first official statement from vaccine manufacturers on the likely efficacy of their shot against Omicron, BioNTech/Pfizer said that two vaccine doses resulted in significantly lower neutralising antibodies but that a third dose of their vaccine appeared to bring antibody protection up to a level equivalent to two vaccine doses against the original strain.

The findings are broadly in line with a preliminary study published by researchers at the Africa Health Research Institute in South Africa on Tuesday, showing that Omicron can partially evade protection from two doses of the Pfizer/BioNTech vaccine.

Updated










16:15










15:59

Updated










15:40










15:24

Capitol attack committee has ‘no choice’ but to advance contempt proceedings against Meadows

Updated










14:57










14:57










14:57

House passes $768bn defense bill in bipartisan vote, despite progressive criticism



Read original article here

Leave a Comment